Luke Arbogast

Company: Eli Lilly & Co.

Job title: Director - Research & Development

Seminars:

PANEL: Using Orthogonal Approaches to Increase Assay Resolution & Accurately Quantify Empty-Full Ratios 2:30 pm

Understanding how to correlate orthologous methods, such as NGS, to qualify AUC and determine genome content Validating ratios by identifying trends appearing from using orthogonal methods in the absence of adequate reference standard materials Determining how to holistically apply empty-full characterization technology to build a fuller picture of genome integrityRead more

day: Day One PM - B

Benchtop TD-NMR: A New Tool for Biophysical Characterization of AAV 5:00 pm

Benchtop time domain (TD)-NMR is an agile noninvasive/nondestructive platform for AAV characterization Benchtop TD-NMR can provide data on AAV attributes such as empty/full ratio in minutes without the need for a dedicated NMR SME Benchtop TD-NMR can provide solutions for characterization of complex therapeutics not generally accessible to traditional high-field FTNMRRead more

day: Day One PM